Change in moles linked to use of unlicensed “sun tan jab” (original) (raw)

Intended for healthcare professionals

  1. News & Views
  2. Change in moles linked...
  3. Change in moles linked to use of unlicensed “sun tan jab”

Letters Melanotropic peptides BMJ 2009;338 doi: https://doi.org/10.1136/bmj.b277 (Published 28 January 2009) Cite this as: BMJ 2009;338:b277

Loading

  1. Ewan A Langan, Walport academic clinical fellow in dermatology1,
  2. Denise Ramlogan, consultant dermatologist2,
  3. Lynne A Jamieson, consultant dermatopathologist3,
  4. Lesley E Rhodes, professor of experimental dermatology1
  5. 1Dermatological Sciences, University of Manchester, Salford Royal NHS Foundation Trust, Salford M6 8HD
  6. 2Dermatology Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD
  7. 3Department of Cellular Pathology, Salford Royal NHS Foundation Trust, Salford M6 8HD
  8. Ewan.Langan{at}postgrad.manchester.ac.uk

We draw attention to a new factor complicating presentation and diagnosis of pigmented lesions1: unlicensed use of melanotropic peptides offered online as Melanotan I and II.

Two patients presented to our dermatology clinic with rapidly changing moles and a conspicuous tan, despite their sun reactive skin type I/II (sunburns easily, suntans poorly). They were both sunbed users. One, a woman of 42, reported two moles on her …

View Full Text

Log in

Log in using your username and password

Log in through your institution

Subscribe from £184 *

Subscribe and get access to all BMJ articles, and much more.

Subscribe

* For online subscription

Access this article for 1 day for: £50 / $60/ €56 (excludes VAT)

You can download a PDF version for your personal record.